Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-Small Cell Lung Cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences